Shukra Pharmaceuticals Ltd vs Zenlabs Ethica Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 33.62 as of 06 May 15:30 . The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 37.1 on March 2021 to 99.3 on March 2025 . This represents a CAGR of 21.76% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 17.9 on March 2021 to 76.1 on March 2025 . This represents a CAGR of 33.57% over 5 years The Market Cap of Shukra Pharmaceuticals Ltd changed from ₹ 6.97 crore on March 2021 to ₹ 956.77 crore on March 2025 . This represents a CAGR of 167.62% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 13.77 crore on March 2021 to ₹ 20.32 crore on March 2025 . This represents a CAGR of 8.09% over 5 years The revenue of Shukra Pharmaceuticals Ltd for the Dec '25 is ₹ 39.95 crore as compare to the Sep '25 revenue of ₹ 7.59 crore. This represent the growth of 426.35% The revenue of Zenlabs Ethica Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Shukra Pharmaceuticals Ltd for the Dec '25 is ₹ 27.95 crore as compare to the Sep '25 ebitda of ₹ 1.29 crore. This represent the growth of 2066% The ebitda of Zenlabs Ethica Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Shukra Pharmaceuticals Ltd changed from ₹ 3.16 crore to ₹ 20.36 crore over 5 quarters. This represents a CAGR of 343.89% The net profit of Zenlabs Ethica Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Shukra Pharmaceuticals Ltd changed from 10.47 % on March 2022 to 4.57 % on March 2025 . This represents a CAGR of -18.72% over 4 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016.
The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

About Zenlabs Ethica Ltd

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

FAQs for the comparison of Shukra Pharmaceuticals Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Shukra Pharmaceuticals Ltd or Zenlabs Ethica Ltd?

Market cap of Shukra Pharmaceuticals Ltd is 1,472 Cr while Market cap of Zenlabs Ethica Ltd is 17 Cr

What are the key factors driving the stock performance of Shukra Pharmaceuticals Ltd and Zenlabs Ethica Ltd?

The stock performance of Shukra Pharmaceuticals Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shukra Pharmaceuticals Ltd and Zenlabs Ethica Ltd?

As of May 6, 2026, the Shukra Pharmaceuticals Ltd stock price is INR ₹33.62. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹26.49.

How do dividend payouts of Shukra Pharmaceuticals Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Shukra Pharmaceuticals Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.